Home > Insider Trading > Filing (0000899243-20-005688)

Filing Details

Accession Number:: 0000899243-20-005688
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-24 21:02:40
Reporting Period:: 2020-02-20

Accepted Time:: 2020-02-24 21:02:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
896262	Amedisys Inc	AMED	Services-Home Health Care Services (8082)	113131700

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1543701	G Scott Ginn	3854 American Way, Suite A Baton Rouge LA 70816	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-02-20	222	$194.12	18,664	No	4	F	Direct
Common Stock	Acquisiton	2020-02-21	11,250	$27.35	29,914	No	4	M	Direct
Common Stock	Disposition	2020-02-21	3,200	$193.24	26,714	No	4	S	Direct
Common Stock	Disposition	2020-02-21	5,921	$194.12	20,793	No	4	S	Direct
Common Stock	Disposition	2020-02-21	2,129	$194.72	18,664	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-02-21	11,250	$0.00	11,250	$27.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
11,250	2019-05-01	2025-05-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,714	Indirect	Through 401(k) Plan

Footnotes

The total amount of shares beneficially owned includes 887 shares held in an employee stock purchase plan account.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.58 to $193.57, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.59 to $194.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.59 to $195.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4.
The information in this report is based on a plan statement dated as of December 31, 2019.
On May 1, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock, subject to time-based vesting. The option vested as to 11,250 shares on May 1, 2019, and the remaining 11,250 options will vest on May 1, 2020, provided that on such vesting date, the reporting person remains continuously employed by the Issuer.